Immediate Impact

1 by Nobel laureates 1 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
2019 Standout
13 intermediate papers

Works of J. C. Dalrymple being referenced

Treatment of hidradenitis suppurativa with the carbon dioxide laser
1987

Author Peers

Author Last Decade Papers Cites
J. C. Dalrymple 71 47 121 126 10 293
Harold W. Jacox 53 42 62 101 9 234
Julie Sandstad 52 102 134 102 14 263
Conrad G. Julian 162 83 115 86 16 318
Edith A. Sijmons 73 207 126 97 11 329
Jeffrey L. Stern 76 121 102 144 13 325
G. Ragusa 85 208 102 120 13 302
Jo-Anne Chin Aleong 44 41 33 65 8 285
Indrojit Roy 43 36 54 52 15 314
Lily Proctor 177 77 84 185 14 330
Marta Parera 21 49 75 109 9 313

All Works

Loading papers...

Rankless by CCL
2026